<DOC>
	<DOC>NCT01281410</DOC>
	<brief_summary>The study is a monocentric, controlled randomized trial. Its an interventional method study. There is a control and an interventional group. The interventional group is receiving a specific inspiratory muscle training with "Respifit" (special device for inspiratory muscle training) during the first 30 days after allogenic stem cell transplantation. The investigators want to show that the training group gets stronger inspiratory muscles. The investigators measure the change of PIMAX values and MVV values.</brief_summary>
	<brief_title>Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>Patients receiving allogenic stem cell transplantation Age 17 80 years old Informed consent Actual pneumonia at the beginning of the trial Impaired vision Patient is not able to handle "Respifit"</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>respiratory muscles</keyword>
	<keyword>hematopoetic stem cell transplantation</keyword>
	<keyword>inspiratory muscle training</keyword>
</DOC>